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A virus was isolated from a rectal swab from a 3 year-old child with acute pneumonia. The extensive syncytia and eosinophilic nuclecir and 
cytoplasmic inclusion bodies observed were indistinguishable from 
those induced by rubeola virus, but serologically, the antigens of 
the isolate were unreactive to rubeola antibodies. Subsequent electron 
microscopy studies indicated that the virus was morphologically iden­
tical to a typical paramyxovirus. In view of these contrasting 
features, further virus characterization was performed.
The genetic material was determined to be RNA by the failure of Actincmycin D to inhibit virus replication. Infected cells stained 
acridine orange contained high concentration of single stranded 
nucleic acids localized in cytoplasmic inclusions. Sensitivity to ether and chloroform electron microscopy studies that the virus part­
icles contained lipid envelopes. Stability to 56 C heat and pH 3.0 
was noted. Filtration and electron microscopy determined the size 
to be within 100-220 nm. Of several different types of red blood 
cells, hemagglutinins to only rhesus monkey cells were detected.
Paired sera from the patient were assayed by serum neutralization 
to several paramyxoviruses and the isolate. Significant increases 
were detected to the isolate and pstrainfluenza 3 representing a 
possibility of a dual infection.
Specific antibodies to the isolate prepared in guinea pigs did 
not react with the other viruses of the paramyxovirus group.
The cultured cells from 8 different species possessed receptor 
sites to the isolate and developed the typical cytopathic responses. 
Animal virulence may be a questionable property since no pathology 
was observed in injected nevtom mice or chicks.
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CHAPTER 1 
INTRODUCTION
Although viruses cause a variety of different diseases, 
the types of responses manifested by most viral infections 
are rather restricted. A few, however, are associated with 
several clinical conditions. For instance, with infections 
by Herpesvirus hominis, replication can occur in various 
tissue sites as the eyes, mouth, genital area, brain, spleen, 
liver and respiratory tract (45, 65, 85, 117, 69). Rhino-
viruses on the other hand remain localized in the nasophar­
yngeal areas (104).
The severity and susceptibility to a viral infection 
in many cases are dependent upon a number of variables such 
as age of the host. For example. Herpesviruses are gener­
ally more lethal to newborn infants (2, 91), in spite of
the presence of maternal immune globulins. Primary infec­
tion of hepatitis A virus is almost asymptomatic in child­
ren but acute among young adults.
The health or immune status of the host upon exposure 
is also ao important factor. Pregnant women or people on 
corticosteroids are in an immunocompromised state and are 
thus less able to control an infection (4, 30, 122). Second­
ary complications by opportunistic bacteria are the freq­
uent consequence of the lowered state of resistance (79).
Viral infections progress when the host’s initial de­
fenses consisting of epitheliod cells have been penetrated.
1
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As a direct approach most of the arboviruses are transmitted 
by insect vectors and skirts the barrier (64, 111). Hepati­
tis B virus similarly enters the body through skin punctures 
with contaminated needles or by scratches from contaminated 
sources. Recently hepatitis B virus was found to be anoth­
er sexually transmittable particle capable of penetrating 
the barrier through sexual frictions (36, 72, 99). Rabies
virus is another well known agent commonly contracted through 
the bites from rabid animals either through the consequences 
of a direct assault or by unsuspected individuals attempting 
to dislodge an item erroneously assumed to be in the animal's 
throat (52). Another direct mode of transmission is by some 
physical trauma as noted with herpatic lesions among wrest­
lers .
Entry via the respiratory route is probably the most 
common means of infection as viral particles are readily 
transported with aerosolized particles or fomites. The 
probability of infection is enhanced by viruses possessing 
neuraminidase, which hydrolyse mucous secretions exposing 
the susceptible cell linings (31, 40, 59, 93). Most entrants 
remain localized in the nasal pharyngeal or upper respir­
atory tracts but occasionally may spread to tissue sites 
resulting in pneumonia or systemic complications (8, 14, 79). 
These viruses are generally known to reinfect the host from 
time to time with the initial exposure frequently being the 
most acute. The specific antibodies in the mucous secre­
tions may be the major factor affecting the course of the
3
infection.
Viruses of the alimentary tract can also be contracted 
by aerosol although the oral route is the most frequent 
means (15, 32, 46, 47, 59). The acid resistant picorna- 
viruses are able to infect by both routes and probably can 
cause the most diverse clinical responses (24, 61)• Certain 
viruses are more restrictive as is hepatitis A virus, which 
penetrates the host defense almost exclusively through the 
enteric system (36).
In the absence of immunoglobulins, virus coming in con­
tact with conjunctival or in some instances even corneal 
tissues, adventitiously in most instances, can seize the 
opportunity to invade through the ocular route (52). Herpes 
virus varicella or even rubella are known to enter the host 
by this avenue (83). Cases of saliva from rabid animals en­
tering the eyes and leading to rabies have occurred but are 
considered rare (52).
CLASSIFICATIONS OF VIRUSES
For many years, when virology was in its infancy, 
considerable confusion existed in viral nomenclature and 
classification. New isolates fulfilling certain basic clas­
sification criteria were designated numbers or coined after 
individuals, location, or even by codes as the bacterio­
phage 0X-174. Clinical manifestations were other means of 
selecting names.
As time progressed and more new viruses were discovered.
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an increasing need to classify viruses that exhibited common 
characteristics into logically organized groups became evi­
dent. Today classification is based on virion properties 
(see table 1) (38, 39, 41, 51, 58). In the future with
further characterizations by newer techniques the major 
categories may be differentiated into additional groups.
As an example, certain viruses in the original Togaviridae 
family have be renamed and placed in a new family,
Bunyaviridae, as these viruses were found to contain trans­
criptase (64). The absence or presence of transcriptase is 
a recent criterion added in the classification order but is 
not used routinely in diagnostic practices (38).
The genetic constitution is the major consideration used 
in the classification scheme, which distinguishes the viruses 
as either containing RNA or DNA. Inhibitors of DNA replica­
tions, such as Actinomycin D, are most frequently used for the 
determination (71, 101). Further classifications are made on 
nucleic acid configuration as single or double stranded based 
on fluroescence with acridine orange (55), which selectively 
stains the single stranded structures.
Morphology of the virions can be observed through electron 
micrography (26, 90). Animal viruses are helical, complex or 
of cubic symmetry with or without a lipoprotein envelope. 
Because of expediency the diameter is frequently determined 
by passage through filters of known porosity (38, 58).
Viruses of man range in size from 200 nm to 300 nm in diam­
eter. Some of the viruses, notably paramyxoviruses and the
TABLE 1
CLASSIFICATION OF VIRAL GROUPS
Enveloped (E)
Virus Nucleic Acid Configuration Capsid Symmetry Naked (N) Transcriptase Size
Adenoviridae DNA D.S. Cubic N No 70-90 nm
Papovaviridae DNA D.S. Cubic N No 40-50 nm
Poxviridae DNA D.S. Helical E Yes 200-300 nm
Herpesviridae DNA D.S. Cubic E No 180 nm
Reoviridae RNA D.S. Cubic N Yes 60-75 nm
Picornaviridae RNA S.S. Cubic N No 15-30 nm
Togaviridae RNA S.S. Helical E No 30-50 nm
Bunyaviridae RNA S.S. Helical E Yes 90-100 nm
Orthomyxoviridae RNA S.S. ■ Helical E Yes 100-120 nm
Paramyxoviridae RNA S.S. Helical E Yes 100-300 nm
Rhabdoviridae RNA s.s. Helical E Yes 60-175 nm
Coronaviridae RNA S.s. Cubic? E Yes 80-120 nm
Retroviridae RNA s.s. Helical E Yes 100-120 nm
D.S.=double stranded, S*S.=sinçle stranded
rhinoviruses, tend to be pleomorphic and are seen under the 
electron microscope as particles of varying sizes and shapes 
(28, 39, 51).
A large number of animal viruses bud through cellular 
membranes of the host cells and in doing so become encapsul­
ated with a lipid coat composed of host membrane which is 
apparently essential for infectivity (1). This feature al­
lows further differentiation. The presence of an envelope 
can be determined by exposing the virus to lipid solvents 
such as ether and chloroform (98). After treatment, viruses 
not capable of infection are designated as enveloped while 
those retaining infectivity are considered naked.
DEFINING AN ETIOLOGICAL AGENT
As implied earlier depending on clinical signs is not a 
reliable method of identifying the etiological agent, since 
many viruses induce the same or similar symptoms (79, 96). 
Even other microbial organisms as bacteria, mycoplasma, 
chlamydia, and protozoans can cause a disease state that are 
clinically indistinguishable from those caused by viruses 
(8, 67, 79, 87). Laboratory protocols in the specific diag­
nosis of viral infections are generally based on three cate­
gories (75, 98): 1) detectable changes in a culture system
after inoculation with a clinical specimen, 2) isolation and 
identification of the infectious agent, and 3) demonstration 
of a rise in antibody titer to the isolate.
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GENERAL PROTOCOL FOR LABORATORY DIAGNOSIS OF VIRAL AGENTS
Selecting the site for collecting a clinical specimen 
should be made on the basis of the apparent signs and symp­
toms (79, 98). Specimens taken from proper sites maximize
the isolation. Respiratory samples are best taken by swabs 
or washings from the throat or nasopharyngeal areas. Erup­
tive exanthemns of the skin, mouth, or genitourinary tract 
should be swabbed directly, but not after healing processes 
have begun♦ Alimentary tract specimens are analyzed through 
a rectal swab or fecal material. In some cases, for example 
in isolating cytomegalovirus, urine is the choice. Cerebral 
spinal fluids or brain biopsies are taken from patients with 
menigitis or encephalitis. Colorado tick fever virus and 
hepatitis B virus can only be isolated efficiently from the 
blood (36, 76). Epstein Barr virus, a herpes virus respon­
sible for infectious mononucleosis, is often isolated in host 
leukocytes (53). Infrequently, rubeola can be isolated from 
the blood but only for a short period during the infection 
(88). Unless there is good evidence that one of the viruses 
found in the blood is involved, routine isolation of virus 
from this source is not commonly done.
TRANSPORT MEDIA
Several kinds of media to transport clinical specimens 
from the physician to the laboratory are available, and a 
selection is primarily an individual preference. The medium 
must function to stablize the virus but not permit other
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microbial organisms to grow. Ideally the specimen should be 
assayed for the presence of virus as soon as possible after 
being taken from the patient (75, 98). In situations where 
the patient is from a distant city where the specimen must be 
mailed, protein source such as bovine serum or albumin is 
generally added (98), to reduce the possibility of virus in­
activation. Antibiotics and antimycotics are also included 
to inhibit bacterial and fungal growth in the specimen. Rec­
ommendation is made to avoid freezing the sample since some 
viruses are unstable if improperly frozen (75, 98).
INOCULATION OF A CLINICAL SPECIMEN
Cell cultures are preferred for isolation and cultiva­
tion of viruses because of convenience, lower cost and 
efficiency (75, 10). The use of laboratory animals and 
embryonated eggs for virus isolation is not only tedious and 
costly, but their susceptibility to infection by many viruses 
is frequently less than tissue culture. Cell lines have 
limitations as well. Different lines and even cell strains 
vary in sensitivity to a given virus. Cultures can become 
infected by mycoplasma with little difficulty (17). In some 
instances fetal calf serum may be toxic for one type of cell 
but not for another.
The primary rhesus monkey kidney cells are generally 
considered the culture of choice for isolation of virus be­
cause of their sensitivity (19, 20). However, rhesus monkeys 
are becoming scarce, and the costs are increasing. Further-
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more, many of these animals harbor latent viruses, which fre­
quently become unmasked after passage and prolonged cultiva­
tion (19). These insidious agents can interfere with adsorp­
tion or replication of other viruses. Fortunately, several 
stable lines free of such viruses are available and are as 
sensitive or nearly as sensitive to most of the viruses (98, 
107). These cell lines are either fibroblastic or epithe— 
loid and are derived from tissues of either human, subhuman 
primate or even canine origin. The selection of lines can­
not be random but must be dictated by thte specific agent be­
ing sought (28, 50, 62, 74, 104, 105, 119). For example,
human cytomegalovirus will not infect epithelioid cells of 
any species and is restricted to human fibroblastic cells 
(37, 103, 112, 123).
DETECTION OF VIRUS
Viral infectivity can be detected in tissue culture by a 
variety of methods. The most common is direct examination of 
the inoculated cells for CPE (cytopathic effect) which can be 
swelling (37), rounding (13, 37, 66, 69, 115), syncytium (3, 
5, 7, 102), vaculation (29) or cell degeneration (88, 70). 
Further effects can be seen in stained slide preparations of 
infected cells. The hematoxylin and eosin stain, which is 
most commonly used, enables detection of inclusion bodies 
that may be located in the cytoplasm (18, 21, 81), nucleus 
(13, 112, 123) or both (49, 88, 121). Inclusions are read­
ily discernible as either basophilic or eosinophilic masses.
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In the absence of any appreciable CPE, presence of cer­
tain viruses can be detected if the virus induces synthesis of 
hemagglutinin. For example, through the hemadsorption 
technique red blood cells (RBC) added to the prerinsed cul­
ture are seen aggragated or clumped on the cell membranes 
after an appropriate incubation period (110). The hemadsorp­
tion technique is used particularly in the detection of ortho­
myxoviruses (influenza) and the paramyxoviruses (60, 110). 
Specificity is also ascertained by adding known antibodies, 
which coat the receptor sites and prevents the red blood cells 
and infected cell interaction (108).
In some cases fluorescent antibodies (41, 68, 73, 78, 80,
106, 109) or enzyme labeled antibodies (9, 10, 16, 33, 46,
86) can be used to detect viral antigens in infected cells 
taken directly from the patient. The procedures are appli­
cable for use on infected tissue culture cells but are not
done routinely because of prohibitive cost. Since the iden­
tity of the suspected agent can only be speculated initially, 
specific antiserum against a multitude of viruses would be 
required in anticipation of obtaining a single positive re­
action. However, if a reasonable assumption can be made on 
a single identity, the procedure offers expediency.
If the nature of the virus cannot be elucidated by using 
any of the methods described, the isolate must then be char­
acterized further by the determination of stability to pH 
conditions and heat (25, 38, 43, 120). Most viruses are in­
activated after passing through the digestive system, part­
icularly from acid pH in the stomach. Consequently virus
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stable at pH 3 is considered capable of infecting the host 
through the alimentary tract. Examples are the enteroviruses 
(24, 64, 82, 97) and adenoviruses (44, 63). Viruses labile
at the low pH conditions must depend on other routes to enter 
the host and generally do so via the respiratory tract. 
Incidentally, the enteroviruses account for a large portion 
of the viral infections probably because of their versatility 
in being able to infect through the nasopharyngeal or res­
piratory tissues and through the intestines.
Certain viruses are rapidly inactivated by heat at 56 C.
One type of protein that could be affected is transcriptase 
encapsulated within the particles of some viruses (88).
Another may be the lipoprotein components comprising the 
envelope of the virion.
Host response to infection can also be used to character­
ize and classify viruses. Distinct pathological lesions and/ 
or specific clinical signs or symptoms can reinforce the sus­
pected identity of the causitive agent (18, 34). In
"cytomegalic" complications in newborn infants, enlarged cells 
with inclusions can often be seen in sedimented urine samples 
stained by the Papanicolon method (37).
The definitive identification must be based upon sero­
logical evidence (75, 107). In most instances the neutrali­
zation test using specific serum prepared by injecting animals 
with a homogenous population of virus free of indigenous 
agents will suffice. In other instances as with Herpesvirus 
hominis types 1 and 2 or the Epstein-Barr virus of Africa and
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and of other areas, more specific serological tests must be 
used (6, 27).
INTRODUCTION TO THE PROBLEM
As part of the graduate training program, students con­
centrating in virology acquire clinical experience at the 
Missoula Diagnostic Laboratory situated in Missoula General 
Hospital in Missoula, Montana. During my assigned period, a 
clinical sample was obtained through Dr. C.E. Bell, a 
practicing pediatrician. An isolate was made and was iden­
tified as rubeola based on cultured characteristics. Other 
criteria such as heat resistancy and antigenic properties 
were not consistent with rubeola. Reinforced by electron 
micrographie examination through the courtesy of Dr. L. Oshiro, 
an electron microscopist with the California State Department 
of Health, Viral and Rickettsial division, the virus was 
identified as a paramyxovirus but of a possibly new type be­
cause of the heat stability properties and antigenic differ­
ences with rubeola virus.
Since the thesis concerns the characterization of the 
isolate , further review will be restricted to the paramyxo­
viruses. For identification purposes the isolate will 
further be referred to as the Hunt virus.
CHARACTERIZATION OF PARAMYXOVIRIDAE
All paramyxoviruses exhibit the properties listed in 
table 2. The RNA composition is single stranded with the en­
capsulated transcriptase serving as template for transcribing
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viral mRNA (38, 51, 58, 116). The nucleoprotein of helical 
symmetry is surrounded with a host acquired lipid envelope 
(116, 121). Low pH and short exposure to elevated heat lead 
to rapid inactivation (12, 18, 37, 38, 43, 49, 58). Electron
microscopy reveals that these pleomorphic viruses range in 
diameter size from 100 nm to 300 nm (12, 18, 42, 49, 58).
The Paramyxoviridae consists of parainfluenza, mumps, 
respiratory synctial (RSV), rubeola, and Newcastle disease 
(NDV) viruses (37, 38, 51, 58). Except for RSV, each con­
tains a hemagglutinin detectable by hemadsorption or hemag­
glutination. Parainfluenza, mumps and NDV hemagglutinate 
guinea pig red blood cells (21, 81, 107, 108, 110) whereas
rubeola agglutinates rhesus monkey red blood cells (12, 42,
49, 88).
All paramyxoviruses produce noticable syncytia in tissue 
culture. Rubeola and RSV both induce extensive CPE, but 
rubeola infections can result in nearly 50 nuclei to each 
syncytia (12, 42, 49, 88) whereas those by RSV generally
are characterized by numerous syncytia with few nuclei (3, 5, 
40). Parainfluenza, mumps, RSV and NDV produce only cytoplas­
mic eosinophilic inclusions, but rubeola induces the pro­
duction of both nuclear and cytoplasmic inclusion as seen in 
Fig. 14 (12, 42, 49, 88).
All members except RSV can be cultivated in the embryo­
nated egg (40). Since all grow in tissue culture, however, 
isolation and cultivation with this system is not commonly 
practiced.
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Table 2
GENERAL CHARACTERISTICS OF THE PARAMYXOVIRUSES
Nucleic Acid 
Configuration 
Presence of Envelope 
Capsid Symmetry 
pH Sensitivity (pH 3)
56 C Heat Sensitivity (30 min)
Transcriptase
Diameter of Virions
RNA
Single stranded 
Yes
Helical
Labile
Labile
Yes
100-300 nm 
(highly pleo­
morphic)
Table 3
SPECIFIC PROPERTIES OF THE HUMAN PARMYXOVIRUSES
Virus H Ad & 
HA
Inclusions 
in T .C .
Growth in Nase Major
Eggs Pathology
in Host
Parainfluenza + C + + URTI,croup
Mumps + C + + Parotitis
Rubeola + N&C + - Coryza,rash
RSV - C — — URTI
NDV + C + + Conjuncti-
vitis
H Ad=hemadsoprtion, HA=hemaggluyinsyion, T.C.=tissue culture 
Nase=neuraminidase, C=cytoplasmic, N=nuclear, URTI=upper 
respiratory tract infection
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Parainfluenza, mumps, and NDV contain a neuraminidase aid­
ing their entry into the host by digesting mucous secretions 
and exposing the membrane (60,93). No neuraminidase has 
been reported with RSV or rubeola (37, 38, 51, 58).
Most of the human paramyxoviruses infect the respiratory 
system as the primary target system, and the infections are 
more often acute in children (8, 21, 22, 59). These viruses
can reinfect the same host, but the clinical response is less 
acute after the third exposure due to the accumulative levels 
of circulating antiserum (54, 79, 94, 95). Rubeola produces 
the most severe respiratory response in children (8, 11, 14,
22, 35, 41, 59, 79, 87, 95) from fever to a disturbing 
dry cough prior to the onset of the erythematous rash. 
Occasionally, secondary pneumonia results (79, 88), but 
certain degrees of neurological effects are much more common 
(84). Parotitis produced by mumps seems to have its highest 
morbidity in children and young adults but inflammations of 
other glands as those of the reproductive organs or pancrease 
are the disturbing concern (18, 34). Parainfluenza and RSV 
both can infect people of any age, but severity is again age 
related with croup or pneumonitis being the common clinical 
response (22., 47, 48, 59, 79, 94, 95) . Although NDV rarely 
infects humans, reported cases have been noted in adults 
afflicted with conjunctivitis contracted from fowl (57).
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STATEMENT OF THE THESIS
The purpose of this study is to describe the Hunt 
virus as a new virus using physiochemical and immunolog 
ical methods.
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CHAPTER 2
MATERIALS AND METHODS
PHOSPHATE-BUFFERED SALINE (Pd)
Ten-times concentrated stock solution of phosphate- 
buffered saline was prepared according to the formula 
described by Schmidt (107) except that the cations, Ca^^ 
and Mg^^, were not added.
NaCl 8 0.0g
KCl 2.Og
Na^HPO^ 11.5g
KH^PO^ 2.0g
Triple distilled H^O l.OL
For the working solution, the stock was first diluted 
ten-fold, and the pH was adjusted to 7.2 with 1 N NaOH or 
1 N HCL. The buffer was poured into milk dilution bottles 
and was autoclaved for 2 0 min.
Before trypsinization the monolayers were routinely 
washed with Pd solution containing 1% glucose. The glucose 
was prepared as a 100 (X) stock solution and was sterilized
by filtration.
TRYPSIN AND TRYPSIN-VERSENE SOLUTIONS
Trypsin powder (Difco) at a final concentration of 
0.25% was suspended in Pd and filter sterilized after adjust­
ing the pH to 7.5. The sterile solution was kept frozen at 
-20 C in 2.0 ml aliquot samples until ready to use.
On occasions, the confluent monolayers resisted the trypsin
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hydrolysis and remained attached to the growing surface.
Such cultures were then treated with a trypsin-versene 
solution, which consisted of NaCl (B.Og), KCL (0.4g), 
glucose (l.Og), trypsin powder (1.5g), NaHCO^ (0.58g), and 
versene (0-2g) in 1 L of triple distilled water. The last 
two chemicals were added after the trypsin had been stir­
ring for 45 min. The solution was then adjusted to pH 7.5, 
filter sterilized and stored at -20C until ready to use.
MEDIA
Eagle’s minimal essential media (MEM), M-199, and NCTC- 
13 5 were all purchased in the dried form from Grand Island 
Biological Company, Bethesda, Maryland, and were used to 
cultivate and maintain the different cell lines used in this 
study. To reduce contamination, 100 U/ml penicillin,lOOug/ml 
streptomycin, and 50 ug/ml gentamycin were routinely in­
corporated in all mediam. When the powdered medium was 
reconstituted with triple distilled water, the pH was adjust­
ed to 7.2 then filter sterilized and stored at 4 C until 
ready to use. Prior to using each pre-warmed medium was 
supplemented with heat inactivated fetal calf serum (Sterile 
Systems Incorporated). Depending on the cell requirements 
or the desired rate of growth 1, 5, 10, or 20% fetal calf
serum (PCS) was used.
All tissue culture media were further supplemented with 
L-glutamine (Sigma). The stock solution was prepared by 
suspending 2.92g in 100 ml of triple distilled water then
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filter sterilized through a 0.22 micron filter (Millipore). 
Five-ml volumes were placed in sterile, capped glass tubes 
and frozen at -2 0 C. For the working solution one ml was 
added to 500 ml of culture media.
Since the pH of maintenance media generally decreased 
much sooner due to the lower serum concentration, tricine 
buffer was also incorporated into the media. The stock 
solution was prepared by dissolving 17.92g of powdered tri­
cine buffer (N-tris-(Hydroxymethyl) methyl glycine) (Cal- 
biochem) in 100 ml of triple distilled water and adjusting the 
pH to 7.2 with either 1 N NaOH or 1 N HCL. After filter 
sterilization through a 0.22 micron pore size filter, the 
stock was stored at 4 C. For use as a buffering system in 
tissue culture media, 5 ml of the stock was added to 500 ml 
of the culture medium.
PRIMARY KIDNEY CELL CULTURE
Guinea pig and rabbit primary cells were cultured using 
the cell dispersion technique with trypsin to obtain single 
cell suspensions from the tissues. Animal donors were 
euthanized with ether (Squibb) and the kidneys removed sur­
gically and aseptically as rapidly as possible. The organs 
were placed in Whirl Pacs (VWR Scientific Inc.) contain­
ing about 25 ml of MEM and 20% FCS with 50 U/ml mycostatin 
(Squibb). Maintaining sterile conditions, the tissues were 
removed from the Whirl Pacs and bathed in a sterile Petri 
plate containing Pd. After detaching the kidney capsule, the
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red cortex was separated from the white medulla section
with sterile scissors. The cortex tissues were then minced
2into approximately one mm pieces maximizing surface area for 
exposure to the trypsin. After washing the tissue fragments 
once in Pd, the pieces were transferred to a sterile trypsin- 
izing flask containing a sterile magnetic stirring bar.
A volume of Pd was added to immerse the tissue complete­
ly . Stirring was then continued at room temperature with a 
magnetic stirrer for 10 min after which the Pd was removed 
by decanting and freshly prepared 0.2 5% trypsin was added.
The first suspension of the treated trypsinized tissues was 
discarded but subsequent treatments were collected by fil­
tration through a sterile gauze. During the collection the 
centrifuge bottles were kept on ice and approximately 25 ml 
of MEM with 20% FCS were added to each bottle to retard fur­
ther trypsin activity. The tissues were trypsinized for 
about seven cycles.
The cells were pelleted by centrifugation at 1,400 rpm 
for 10 min. Braking or friction to the armature was mini­
mized to prevent swirling which would have otherwise caused 
the cells to enter into the solution again. The supernatant 
fluid from each bottle was removed by suction, and the pellet­
ed cells were resuspended in MEM plus 20% FCS with 50 U/ml
of mycostatin at a ratio of one ml packed cells to 200 ml
2of media. Twenty five cm flasks (Corning) were seeded with
2 2 5 ml of suspension, while 75 cm flasks (Corning) and 150 cm
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flasks (Corning) were seeded with 20 ml and 40 ml 
respectively. The atmosphere was exchanged with a mixture 
of 5% CO 2  and 95% air to maintain proper pH of the medium 
during the initial stage of attachment and growth. All 
primary cultures were left undisturbed for 3 days to enhance 
attachment.
PRIMARY HUMAN FORESKIN AND RABBIT CORNEA
Certain tissues resist trypsinization and require other
methods in order to obtain monolayered cells. Two such
tissues are the human foreskin (HE) and rabbit cornea y
which were processed by the plasma-clot method (107). The
HE tissues were obtained from circumcised infants and were
kindly provided in transport media by the nursery personnel
at Missoula Community Hospital.
Rabbit cornea was aseptically removed from a sacrificed
animal and transported to the culture laboratory in a Whirl
Pac containing NCTC—135 plus 20% ECS with 50 U/ml mycostatin.
Under sterile conditions the tissues were minced into 
2small one mm sections then rinsed several times in Pd.
Using a bent, sterile Pasteur pipet with a rubber bulb, each 
tissue was "picked up" by low negative pressure, dipped in 
chicken plasma (Difco) and placed in plastic tissue culture 
flasks approximately one cm apart across the bottom surface- 
Kkcess fluid surrounding the tissue was removed by suction. 
Each tissue section then received one drop of chick embryo 
extract (Difco). After incubation for one hour, a clot de-
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veloped anchoring the tissues to the culture surface. The 
medium NCTC-135 with 2 0% FCS was slowly added with caution 
taken to prevent dislodging the tissues. The atmosphere was 
again exchanged with a mixture of 5% CO^ and 95% air.
CHICK EMBRYO FIBROBLAST CULTURES
Embryonated chicken eggs, donated by the Rocky Mount­
ain Laboratory, were incubated under humid conditions at 37 C 
in a hatching incubator (Humidaire Incubator Co.). Nine-day 
old embryos were removed asceptically and cut into 3 sections, 
washed in Pd and placed in a sterile trypsinizing flask con­
taining a magnetic stirring bar. After 10 min washing with 
Pd the solution was replaced with freshly prepared 0.25% tryp­
sin solution. Three min trypsinization intervals were con­
tinued until almost all tissues were trypsinized. Cells were 
collected by centrifugation as described previously. One ml 
of packed cells was suspended in 300 ml of M-199 supplement­
ed with 10% FCS.
STABLE CELL LINES
Several stable cell lines used in this study were pro­
cured by Dr. Richard Ushijima and were held under liquid 
nitrogen storage. Upon removal of the cells from the -7 0 C 
or liquid nitrogen, the vials were warmed immediately under 
running water. The cells were removed and centrifuged at 
1,400 rpm in 10 ml of medium. The cell pellets were re­
suspended in NCTC-135 with 20% FCS and dispended into cul­
ture flasks under the same conditions as described earlier.
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When the monolayers had become confluent as determined 
by visual observation through an inverted microscope, the 
cells were subcultured into desired containers. Passages 
or subcultivation of all cultures were made as follows.
The expended medium was removed and the monolayers washed 
several times with Pd containing 1% glucose. After the last
wash, one, three, and five ml of trypsin with versene was
2 2 2 added to monolayers in 25 cm , 7 5 cm , and 150 cm flasks
respectively and incubated at 37 C until cells detached from
the surface of the flasks. Ten ml of MEM with 10% FOS was
added immediately, and the cells were removed by repeated
suction to enhance formation of single-celled suspensions.
Upon centrifugation for 5 min at 1,400 rpm at 4 C the cell
pellet was resuspended in MEM and 10% FCS.
The cell concentration of each suspension was determined
in a hemocytometer to maintain proper density. With the
exception of HeLa cells, all other stable and diploid cells
were adjusted to a cell concentration of 2.5 x 10^ cells/ml.
HeLa cells were suspended to 2.0 x 10^ cells/ ml.
INFECTION OF CELLS
Cells were infected with viral inocula directly from the
infected stock suspensions or were diluted in medium used to
culture the particular cells under study. Leighton tubes or 
225 cm flasks received 0.5 ml of the viral suspension, but
2 2 75 cm flasks and 150 cm flasks were inoculated with one-ml
volumes. Adsorption to cells by viruses were routinely per-
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mitted to proceed for one hour after which the inocula were 
removed. The cultures were then washed in Pd and refed with 
maintenance media. Depending on the need, virus inoculated 
cells were either fixed and stained after CPE was observed 
or, in the case of preparing a virus pool, allowed to reach 
80% infectivity in order to obtain high titers of virus.
All virus samples collected were stored at -70 C.
VIRUS TITRATION BY 50% TISSUE CULTURE INFECTIOUS DOSE 
ENDPOINT
All pools of virus were titered for infectivity using 
the TCID^q method (50% tissue culture infectious dose end­
point) described by Reed and Muench (100), Sterile flat 
bottom tissue culture microtiter plates (Falcon) were used 
to perform most virus titration while others were done in 
test tubes. To each of the 96 wells 0.05 ml of MEM plus 
10% FCS were added with sterile disposable droppers (Micro­
biological Associates). All wells, in the last two rows also 
received an additional 0.05 ml of media serving as cell 
controls. Starting from the virus stock, serial ten-fold
— 7dilutions were made down to a 10 dilution in test tubes
using MEM plus 10% FCS as the diluent. Each of the first
—  1ten wells in the first row received 0.05 ml of the 10
dilution. The first ten wells of the second received
— 2 —70.05 ml of the 10 dilution and so on through the 10
dilution. Plates were covered with sterile lids (Micro­
biological Associates) and placed in an airtight box.
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Air mixed to 5% CO^ and 9 5% air was flushed into the box
through connective tubing to maintain proper pH. Humid con­
ditions to prevent evaporation was achieved by placing a 
small beaker filled with water inside the box. Plates 
were observed daily for evidence of viral CPE in each well.
The 50% endpoint of the virus infectivity was calculat­
ed and the dilution leading to the 50% endpoint was con­
sidered one TCID^q . For all serum neutralization tests 
done, virus pools were diluted in order to give 100 TCID^^ 
in 0.05 ml of suspension.
STAINING WITH HEMATOXYLIN AND EOSIN STAIN
For histological differentation infected monolayers 
were stained with hematoxylin and eosin. Fixed slides were 
stained thirty min with Erlich's hematoxylin, then counter­
stained for five min with eosin. Stained slides were mount­
ed with mounting media and coverslips and observed under 
light microscopy.
CHAPTER 3 
RESULTS
PLAQUE PURIFICATION OF THE HUNT VIRUS
Using the plaque purification technique described by
Schmidt (107) a pure virus population can be achieved. Four
ml of freshly trypsinized Vero cells were seeded into sterile
30 mm plastic Petri dishes (Corning) and incubated one day at
37 C in a humid box with an atmosphere of 5% CO 2  and 95% air.
Viral dilutions of the original Hunt virus were made from 
-1 -710 to 10 in MEM with 1% FCS and 0.2 ml of each dilution 
adsorbed for one hour to cells of individual Petri dishes. 
Removal of unadsorbed virus was accomplished with three Pd 
washings. Nutrient agar overlays contained an equal volume 
of 2 X MEM plus 10% FCS and sterile purified 2% agar (Difco) 
that were mixed together at 46-47 C. Five ml of the mixture 
was poured into each Petri dish. The overlay was allowed 
to harden for 20 min at room temperature, then 5 ml of MEM 
with 1% FCS was added over the top in order to maintain 
better pH. All dishes were placed in a humid box at 3 5 C 
with 5% CO^ and monitored daily for plaque formation.
Plaques began to appear three days after inoculation 
but were allowed to develop one day further for easier de­
tection. Three plaques were observed in the Petri dish 
inoculated with the 10  ̂ dilution, two of which were less 
than 10 mm apart, the third approximately 20 mm from the 
others. The most distant was selected for preparing the
pool since contaminating virus from neighboring plaques was
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less likely (89, 107). With a sterile Pasteur pipet, agar 
and cells within the plaque were removed by suction and di­
luted in one ml of MEM with 1% FCS. Cell fractionation and 
agar disruption was achieved by sonication. Debris was 
removed by centrifugation at 3,000 rpm. The entire pro­
cedure for plaque purification was repeated from a suspen­
sion of the new pool.
DETERMINATION OF NUCLEIC ACID
The genetic constituency of the Hunt virus was deteirm- 
ined by using»Actinomycin D, an inhibitor of DNA transcrip­
tion and duplication (101). Actinomycin D binds to DNA of 
viruses with a DNA dependent RNA polymerase.
Duplicate cultures of the confluent monolayers of 
Vero cells passed one day earlier were rinsed with Pd, 
inoculated with 0.2 ml of the different viruses or equal 
volume of medium only then reincubated with one ml of MEM 
plus 1% FCS containing 5 ug/ml of Actinomycin D according 
to the method of Reich and Franklin (107)i The inhibitory 
function of the drug based on cytopathic changes was de­
termined three days later and the results are shown on 
table 4.
Since herpesviruses are DNA viruses, Actinomycin D 
prevented the infection from progressing to the cytopathic 
stage as expected. Similarly being an RNA virus independ­
ent of any DNA nucleotides, cells infected with rubeola be­
gan to develop the typical syncytium. Cells infected v/ith
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Table 4
The effects of 5 ug/ml of Actinomycin D on re­
plication of rubeola, herpesvirus and the Hunt virus 
based on cytopathic changes
CPE AFTER
VIRUS TREATMENT THREE DAYS
*rubeola yes +* *no +
*herpes type 1 yes —* *no +
*Hunt virus yes +* *no +
■kcell control yes —* *no
(*) treatment with Actinomycin D
(**) no treatment with Actinomycin D
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the Hunt virus continued to undergo degenerative changes 
and were not affected by the presence of Actinomycin D.
Using the method outlined by Humason (55), acrldine 
orange can be used to distinguish between the nucleic acid 
configurations of infecting viruses in most cases. When 
infected cells are stained the dye binds firmly to the 
chains of single stranded nucleic acid and only lightly to 
the double stranded nucleic acid. Double stranded struct­
ures fluoresce bright yellow or green and single stranded 
red to orange under ultraviolet microscopy. Color of 
viral infected cells appears more intensely localized 
at sites of high virus concentration than nucleic acids 
of normal cells.
Vero cells grown on glass slides (VWR Scientific Inc.) 
in Leighton tubes were inoculated with Herpesvirus hominis, 
rubeola and the Hunt virus. When CPE began to develop, the 
slides were fixed in a 1:1 ether-95% ethanol for 15 sec.
The slides were hydrated through 7 5%, 50%, 2 5% ethanol
baths and finally double distilled water. After rins­
ing briefly in 1% acetic acid and a few min in distilled 
water, the slides were stained for three min with acridine 
orange solution (Sigma). Excess stain was removed by rins­
ing in 0.15 M phosphate buffer for one min. Differentia­
tion was achieved with a 30 sec bath in 0.10 M CaCl^• 
Calcium ions were removed with a thorough washing in 
phosphate buffer. The slides were mounted in buffer and 
coverslips and were observed under fluorescent microscopy
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ing in 0.15 M phosphate buffer for one min. Differentia­
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phosphate buffer. The slides were mounted in buffer and 
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at 450 run as quickly as possible to avoid fading and drying.
Figure 1 is a photomicrograph of uninfected Vero cells 
stained with acridine orange. The cytoplasm can be seen as 
dull brick red masses surrounding the green-colored nuc­
leus. In contrast the cytoplasm of the cells in figure 2 
infected with rubeola virus appeared intensely red-orange.
In both cases the staining properties of the nuclei were not 
discernible. In figure 3, cells infected with herpesvirus 
did not emit the red or orange fluorescence. When the stain­
ed Hunt virus infected cells were observed under the micro­
scope , the fluorescence was similar to those of the rubeola- 
infected cells (Fig.4). The inclusions seen in acridine 
orange preparations appeared orange indicating a pool of 
single stranded nucleic acid.
ETHER AND CHLOROFORM SENSITIVITY
Lipid solvents as ether and chloroform are invaluable 
to a clinical laboratory in determining the outer compo­
sition of the viral particle. Viruses inactivated by one 
of those solvents are designated as "enveloped" indicating 
the presence of lipids as an integral structure in contrast 
to the "naked" viruses with capsomers void of any lipid 
fractions. To 0.8 ml of the viral suspension, 0.2 ml of 
anaesthetic ether (Squibb) was added. All materials were 
pre-chilled to 4 C. After capping the tubes securely, strips 
of Parafilm (VWR Scientific) were wrapped around the caps 
to prevent solvent evaporation. The contents were then mix-
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Figure 1: acridine orange stain of normal 6 dayVero cells 400 (X)
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Figure 2: acridine orange stain of 5-day rubeola
infection on Vero cells 400 X
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Figure 3 : acridine orange stain of 2-day Herpes­
virus hominis infection on Vero cells400X
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Figure 4 : acridine orange stain of 5-day 
infection with the Hunt virus 400X
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ed thoroughly by swirling and incubated overnight at 4 C.
The suspensions were then poured into sterile Petri dishes 
and the ether was permitted to evaporate at room tempera­
ture with the cover slightly jarred. Infectivity was fin­
ally determined by inoculating in duplicate cultures of 
Vero cells.
Chloroform sensitivity was also determined. The suspen­
sions and solvent were prepared as with the ether study but 
the incubation was maintained for only 3 0 min. Chloroform 
was separated from the virus suspension by centrifugation 
at 3,000 rpm for 10 min and the upper solvent phase contain­
ing treated virus was removed. Residual chloroform was fur­
ther removed by bubbling with nitrogen gas. Treated and un­
treated suspensions were inoculated in duplicate into Vero 
cell tubes. The results of the determinations are recorded 
in table 5.
As a naked particle lacking in the capsid, poliovirus 
retained its infectiousness after exposure to either solvent 
On the other hand, rubeola virus and the Hunt virus no long­
er were able to infect the indicator cells after the pre­
scribed incubation in ether or chloroform.
pH SENSITIVITY
The sensitivity of viruses to low pH is one criterion 
used in the classification scheme. Those particles maintain
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Table 5
Sensitivity of rubeola, polio and the Hunt 
virus to ether and chloroform:
VIRUS SOLVENT CPE OBSERVED 
ON CELLS AFTER THREE DAYS
rubeola ether nochloroform no
none yes
polio ether yeschloroform yes
none yes
Hunt virus ether nochloroform no
none yes
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ing infectivity are generally considered capable of host 
entry through the alimentary tract. To determine the labil­
ity of the Hunt virus to the acidic conditions, the viral 
suspension was diluted 10-fold in Hank's balanced salt sol­
ution at pH 3.0 as described by Kelter (66). Another set 
in diluent at pH 7.2 was included as medium control. Rub­
eola, sensitive to low pH, and poliovirus, resistant to acid 
pH, were similarly treated and served as system controls.
One set of each duplicate sample was incubated at 4 C for 30 
min and another for 60 min. The suspensions at pH 3.0 
were then adjusted to pH 7.2 with sterile 1 N NaOH at the 
end of each incubation period. Retention or loss of in- 
fectivity was determined after seven days using syn­
cytium and cytopathic changes as the criterion.
Table 6
The effect of pH 3.0 on rubeola, poliovirus and 
the Hunt virus :
CYTOPATHIC EFFECT ON VERO CELLS 
VIRUS pH 3 30 min pH 3 60 min pH 7.2 30 min pH 7.2 
______________________________________________________ 6 0 min
rubeola - - + +
polio + + + +
Hunt virus + + + +
As shown in table 6, the Hunt virus was not activated 
at pH 3,0 for either 30 min or 60 min similar to those of 
the poliovirus. Rubeola virus on the other hand was in­
activated at pH 3,0.
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HEAT SENSITIVITY
Most viruses are rapidly inactivated at temperatures 
between 56-60 C. Although response to heat is not used 
extensively in viral classification, the information can be 
of value, particularly in so far as the unknown Hunt virus 
is concerned. As indicated earlier the Hunt virus was ten­
tatively considered as rubeola virus based on cultural re­
sponse. Since the paramyxoviruses are unstable at elevat­
ed temperatures, the heat sensitivity test was performed as 
a matter of course to support the expected results from the 
anticipated fluorescent antibody assay. The Hunt virus re­
tained its infectivity. This suggested that suspension 
contained two species of virus or that the virus was not 
rubeola.
To perform the test one ml of each stock of plaque pur­
ified viral suspensions of the Hunt virus and rubeola 
virus were added to several tubes, which were emmersed in 
a water bath set at 56 C. At 15 min intervals during the 
first hour and at 30 min intervals thereafter, one tube of 
each viral suspension was removed and placed immedi­
ately in ice before determining infectivity on indicator 
cultured cells. A duplicate set was carried where the 
tubes were incubated in an ice bath to ascertain that loss 
of infectivity was not attributed to the lowered tempera­
ture conditions.
As shown in figure 5, the rubeola virus with a 10^
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TCIDgg per ml rapidly loss all infectivity within the first 
15 min when incubated at 56 C- In contrast the infect­
ivity titer of the Hunt virus remained stable for 90 min,
2At 120 min approximately 10 TCID^g/ml of infectivity 
remained. All the Hunt virus was completely inactivated 
by 180 min. Both viruses maintained at 4 C retained the 
original titer of virus in the 4-hour samples.
610
510
410 rubeola @ 4 C 
Hunt virus310
210 -rubeola @ 56 C
Hunt virus110
010
0
1 2 3 4hours
Figure 5 Heat sensitivity of rubeola and the 
Hunt virus over time
SIZE DETERMINATION
Size of the Hunt virus was determined by filtration 
method using Millipore filters with pore sizes of 0.45 um, 
0.22 um, 0.10 um, and 0.05 uip. Ten ml samples of the virus 
stock were filtered by positive pressure through the vari­
ous size filters previously sterilized by autoclaving. The 
filtered suspension was collected in sterile glass tubes, 
and 0,2 ml of each sample was inoculated on culture cells.
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After adsorbing for one hour and refeeding with MEM plus 1% 
PCS, daily monitoring of the cells proceeded for seven days 
at which time results were recorded (table 7). Rubeola 
virus was also run through filters of the same pore size 
as known control.
Table 7
Size of virions of rubeola and the Hunt virus deter­
mined by filtration:
VIRUS_________PORE SIZE________CPE OBSERVED ON CELLS*
rubeola unfiltered yes0.45 um yes
0.22 um yes
0.10 um no
0.05 um no
Hunt virus unfiltered yes
0.4 5 um yes0.22 um yes
0.10 um no
0.05 um no
cell control - no
* after 7 days 
HEMAGGLUTINATION
Many viruses possess agglutinins, which are capable of 
binding animal red blood cells with specific receptor sites. 
By forming lattices while settling, the erythrocytes agglut­
inate, which can be distinguished at the bottom of the tube.
Erythrocytes from five different animal species were 
used. Rubeola was tested simultaneously with the same pool 
of red blood cell suspensions. Fresh blood cells from guinea 
pigs, sheep, day-old chicks, rheusus monkeys, and type O
41
human were collected in equal volumes of sterile Alsev- 
er's anticoagulant solution until ready for use. Rheusus 
monkey red blood cells were obtained from Oregon Primate 
Center, Beaverton, Oregon. Blood from other animals was 
assayed the same day collected. Prior to use, cells were 
washed four times with PBS at pH 7.2 before making a 
final 0.4% suspension in PBS. A final concentration of 1% 
FCS was added to promote erythrocyte settling. In V-bottom 
microtiter plates (Cooke) all wells from the second well 
of each row received 0.05 ml of PBS by calibrated dropper.
A 0.10 ml volume of rubeola and the Hunt virus was added 
to the first well of each row and diluted serially two­
fold with 0.05 ml dilutors through the eleventh well. The 
twelveth wells served as cell controls. To each well, 0.05 
ml of erythrocyte suspension was added. Plates were allow­
ed to remain undisturbed for one hour before reading (tab­
le 8) .
Hemagglutination with both viruses was seen only with 
red blood cells from rhesus monkey. The cell controls 
indicated agglutination was not due to nonspecific factors. 
Rubeola and the Hunt virus hemagglutinating titers were 
4 and 8 respectively.
SEROLOGICAL DETERMINATION
Whereas all of the procedures described thus far are 
used to classify viruses, the specific identity is depend-
Table 8
Hemagglutination characteristics of rubeola and the 
Hunt virus with RBC from different animal species
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VIRUS ANIMAL CELLS HEMAGGLUTINATION TITER
rubeola guinea pig no <2
sheep no <2
chick no <2
human O no <2
rhesus monkey yes 4
Hunt guinea pig no <2
sheep no <2
chick no <2
human O no <2
rhesus monkey yes 8
cell guinea pig no —controls sneep no
chick no —
human O no —
rhesus monkey no —
5 9
SUMMARY OF THE HUNT VIRUS CHARACTERISTICS
Nucleic acid RNA
Configuration single stranded
Enveloped yes
pH 3 sensitivity stable
56 C sensitivity stable
Size 100-220 nm
Hemagglutination yes, with rhesus 
monkey red blood 
cells
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ent upon the serum neutralization (SN) assay, in which the 
specific antibody molecules neutralize the infectivity of 
the agent for the indicator system. In at least one group
of viruses as Herpesvirus hominis, the two types are
distinguishable by the higher titer of neutralizing anti­
body produced by the infecting type. Exceptions to the SN 
exist, one of which is with the orthomyxovirus, influenza 
type A, which can undergo mutation of the hemagglutinating 
antigen resulting in a "major shift". In most of the 
other serological procedures, the techniques are used for 
expediency or to detect minor antigens.
Since the Hunt virus appeared to be a paramyxovirus
based on electron microscopy performed by Dr. Lyndon Oshiro 
at the California Department of Health, Viral and Rick­
ettsial Division, and on the cytological markers, the SN 
test was conducted using specific antisera obtained from 
the National Institutes of Health in Bethesda, Maryland, 
against rubeola, RS, parainfluena 3 and canine distemper 
viruses.
The SN method used is described accordingly. To all 
wells except in the first row of a sterile flat-bottomed 
microtiter plate (Falcon) 0.05 ml or one drop of MEM con­
taining 5% FCS was added asceptically with micropipet drop­
pers followed by one drop of heat inactivated serum to the 
first two rows. Serial two-fold dilutions were then made 
from the second well with alcohol-sterilized microdilutors
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(Cooke) pretested for proper delivery on ultraviolet- 
sterilized "Go—No-GO" blotters (Cooke). To each well one 
drop of viral suspension containing 100 TCID^q of the test 
virus was added. After the plates were incubated at room 
temperature for one hour for the antibody-antigen inter­
action to proceed, Vero cells at a concentration of 2.5 X 
10^ cells/ml were added to all wells.
After further incubation in a humidified chamber 
where the air was exchanged with a gas mixture of 95% air- 
5% CO 2  each well was examined through the inverted micro­
scope for CPE.
If the Hunt virus was the cause of the illness, a diff­
erence in titer should be measured between the acute and 
convalenscent sera. In clinical diagnosis, a rise in 
titer of four-fold or greater indicates that an infection 
had occurred.
Since the infant was ill with pneumonia, the SN assay 
was performed against rubeola, parainfluenza 3, RSV and the 
Hunt virus. According to the results in table 10, a 16-fold 
and a 4-fold increases were noted in the titer determined 
against the Hunt virus and parainfluenza 3 . Titers to
rubeola were high without showing significant differences 
between the two serum samples.
To ascertain the specificity of the different viruses 
and the antisera, cross neutralization assays were conduct­
ed (table 11). Each virus and antisera did not cross react.
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The SN titers against the Hunt virus were, therefore, not
due to any of the other viruses. Specific antisera to
rubeola, parainfluenza 3 and RSV had titers of 1024, 512
and 1024 respectively. Antisera to the other viruses had
neutralizing titers less than 4. Likewise, no antisera to
the other viruses had neutralizing titers to the Hunt virus
Table 10 The antibody titers of the patient to rubeola,
parainfluenza 3, RSV and the Hunt virus determin­ed by serum neutralization
Table 11
VIRUS ACUTE TITER CONVALESCENT TITER
rubeola 512 256RSV <2 <2parainfleunza 3 8 32
Hunt virus 32 512
Determination of antisera and virus specificitybased on serum neutralization
VIRUS ANTISERUM TITER
rubeola canine distemper <4rubeola 1024
parainfluenza 3 <4RSV <4
parainfluenza 3 canine distemper <4
rubeola <4
parainfluenza 3 512
RSV <4
RSV canine distemper <4
rubeola <4parainfluenza 3 <4
RSV 1024
Hunt virus canine distemper <4
rubeola <4
parainfluenza 3 <4
RSV <4
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To ascertain further that the Hunt virus was antigen- 
ically distinct from the other paramyxoviruses, specific 
antiserum was prepared against the Hunt virus and another 
SN assay was subsequently conducted.
The antisera was made in guinea pigs infected with the 
plaque purified isolate propagated in kidney cells of 
guinea pig origin in medium consisting of MEM with 10% 
heat inactivated guinea pig serum. The injection prep­
aration was initially made by adding 0.5 ml of the virus 
pool to 0.8 ml of sterile Arlacel A (Sigma) and 4.3 ml of 
sterile mineral oil. The combined products were mixed in 
a mortar and pestle then through a micro-emulisifying 
needle (Bolab Inc.) united by 2 glass syringes.
Two weeks before the injection, serum was collected 
from each animal. Each guinea pig was then injected with 
2 ml of the suspension distributed equally at sites near 4 
inguineal lymph nodes. Two weeks later an intravenous 
booster injection of 0.5 ml of virus suspension was given.
A small portion of a virus suspension was aerosolized in­
to the nasal passage. One week following the booster, 10 ml 
of blood was asceptically drawn by cardiac puncture and 
allowed to clot overnight at 4 C. After centrifugation at
2,00 0 rpm for 10 min, the serum samples from each animal 
was collected and assayed. The results are recorded in 
table 12 indicating that the antisera did not contain 
antibodies reactive with rubeola, parainfluenza 3 and RSV 
but contained antibodies with titer to 512 against the Hunt
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virus.
To determine the wide spread nature of the Hunt virus, 
another SN assay was conducted using serum sources from 
several cattle and humans randomly selected. The results 
are listed in table 13. Several human and cattle sera 
contained high antibody titers indicating that the Hunt virus 
is not a recent "genetic creation" but one that is apparently 
widespread.
Table 12 Determination of serum neutralizing antibodies to 
rubeola, parainfluenza 3, RSV and the Hunt virus 
using antisera prepared against the Hunt virus.
VIRUS ANTIBODY TITERS
_____ P RE-INJECTION______________________ POST - INJECT I ON
rubeola <2 < 2
parainfluenza 3 "=̂ 2 <2
RSV <2 <2
Hunt virus < 2 512
Table 13 Titers to 100 TCID^q of the Hunt virus determined 
by serum neutralization with randomly selected 
human and cattle sera
SERUM TITER
COW # 524 512
cow # 476 256cow # 1087 128
COW # 254 < 2
COW # 4 < 2
COW # 713 512
human 1 , RU 4
human 2, JF 128
human 3, PL < 2
human 4, TH 1024
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FLUORESCENT ANTIBODY ASSAY
The indirect antibody assay (IFA) is a sensitive system 
for the detection of viral antigens or the presence of an­
tibodies to known viral antigens (68, 73, 78, 80, 86). Al­
though the SN studies indicated that the Hunt virus was 
antigenically distinct from the other viruses of the para­
myxovirus group, the IFA may reveal common antigens not 
detectable by other serological techniques. To determine 
whether the isolate shares such an antigen, the studies des­
cribed below were conducted.
A. PURIFICATION OF GUINEA PIG IMMUNOGLOBULINS
As described earlier antiserum to the Hunt virus was 
prepared in the guinea pig. The anti-guinea pig gamma­
globulin required for conjugation with fluorescein was made 
in rabbit by injection with purified guinea pig gamma­
globulins, which was prepared by the method of Steinbuch 
(114). The guinea pig serum was first adjusted to pH 5.5-
6.0 with I’N acetic acid, and the ablumin fraction was then 
precipitated by adding dropwise octanoic acid equalling 6% 
of the serum volume. After 30 min of continual stirring, 
the precipitate was removed and the pH readjusted to 7.2 
with IN NH^OH. To precipitate the globulins, saturated 
(NH^) was added at a final concentration of 35%. Three 
hours following continual stirring, the globulin was pellet­
ed by centrifugation at 15,000 rpm for 10 min. The globulin 
was dissolved in sufficient saline to solubilize the preci-
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pitate. The residual ammonium sulfate was removed by di­
alysis against distilled water at 4 C.
Protein concentration of the suspension was determined 
by the Lowry method (77) and adjusted to 1 mg/ml in 0.8 5% 
saline. An incomplete Freund's adjuvant was prepared with 
the immunoglobulins, and 2.0 ml was injected into a rabbit 
intramuscularly. Two weeks later, a 0.5 ml booster was in­
jected intravenously. After an additional week the blood 
was collected, the serum removed and the globulins puri­
fied by the method of Steinbuch (114) as described.
B. CONJUGATION
Fluorescein isothiocyanate (Sigma) was conjugated to 
the guinea pig antibodies according to the method des­
cribed by Lyerla and Forrester (78). Protein concentra­
tion of the globulin was adjusted to 2 0 mg/ml in saline. 
With continuous stirring, a volume of 0.2 M Na^PO^ equal­
ing half the volume of the globulin solution was slowly 
added. The pH was adjusted to 9.5 by adding dropwise 
0.1 M Na^PO^. The final volume was then adjusted with 
0.85% saline to a protein concentration of 10 mg/ml. Five 
ml of the suspension was placed into dialysis tubing and 
submerged in a solution containing 6.25 mg of fluorscein 
isothiocyanate dissolved in 50 ml of 0.1 M Na^HPO^ that 
was adjusted to pH 9.5 with 0.1 M Na^PO^. Conjugation 
proceeded for 15 hours at room temperature in the dark. 
Unreactive fluorescein was removed by dialyzing against
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several fresh changes of PBS. The conjugate solution was 
filtered through a 0.45 um Millipore filter to remove any 
prepipitate and were frozen at -20 C in one ml aliquots. 
Conjugate purity and specificity were ascertained by 
immunoelectrophoresis.
C. FLUORESCENCE ASSAY
Vero cells were infected with the known viruses.
When CPE was observed, the cells were scraped from the 
culture surface with a rubber policeman, pelleted by cen­
trifugation and washed once in Pd. The cells were re­
suspended in one ml of Pd and dropped by Pasteur pipet 
into each well of toxoplasma slides (Bellco Glass Inc.), 
which were then air dried and fixed in cold acetone for 
10 min at 4 C.
The IFA tests proceeded according to the method 
described by Lyerla and Forrester (78). Each slide con­
tained the following: 1) cell control, 2) conjugate
control 3) known positive antisera to the test virus 
(if available), 4) known positive sera control, 5)iso­
late preserum control. During the first 37 C incubation, 
cell and conjugate controls received drops of PBS and 
other wells one drop of serum. The slides were incubated 
for 3 0 min in a humid box at 37 C and unreactive sera 
was removed from the slides by washing 4 times with fresh 
changes of PBS for 5 min each while continually stirring.
After the washing cycle, the slides were air dried, and
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one drop of the conjugate diluted 1:10 in PBS was filter­
ed through a 0.4 5 um filter and added to each well. In­
cubation and post washes were performed as indicated earlier. 
Following the last wash the slides were rinsed briefly in 
distilled water. After air drying, the slides were mounted 
with low fluorescence immersion oil (Zeiss) and No. 1 
thickness cover slips (VWR Scientific). The fixed cells 
were observed under ultraviolet microscopy with an American 
Optical Series 20 microscope. The results are recorded in 
table 14.
Antisera against the Hunt virus showed a specificity 
only to cells infected with the Hunt virus. A slight posi­
tive reaction was seen to parainfluenza type 1 infected 
cells, but since the conjugate control also was slightly 
positive, the fluorescence was probably due to nonspecific 
causes.
The IFA method was also used to detect antibodies 
for known viruses present in the guinea pig sera prepared 
against the Hunt virus. Cells infected with the Hunt virus 
were prepared on slides as previously described. Virus 
antisera obtained from the National Institutes of Health, 
Bethesda, Maryland, were diluted 1:4. The results were 
recorded in table 15.
High fluorescence to the Hunt virus infected cells was 
only observed with the Hunt virus antisera. One pool of 
rubeola antisera gave a +1 positive fluorescence, but an­
other rubeola antisera pool was not reactive.
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Table 14 Hunt virus antiserum assayed against known viruses 
by indirect fluorescent antibodies
VIRUS CC CgC PA PAC HI AIC HP HPC
rubeola — + 4 - - - — -
RSV — - 4-3 - - - — —
PI-1 — + 2 NA 4-2 4-1 4-1 4-1 4-1
PI-2 - - NA - - - - —
PI-3 - - 4-3 - - - - -
NDV - - 4-2 — - - - -
SV-5 — - NA — - — — —
CD — - NA - — - - —
Hunt virus — — 4-4 — 4-4 — — —
CC=cell control/ CgC=conjugate control, PA=positive 
antisera, PAC=positive antisera control, HI=antiserum 
to Hunt virus, AIC=antiserum to Hunt virus control, 
HP=Hunt virus preserum, HPC=isolate preserum control, CD=canine distemper, NA=not available
Table 15 Antisera to known viruses assayed against the 
Hunt virus infected cells by indirect fluorescent anti­
bodies
CELL CONJ. SERUM DEGREE OF
ANTISERA CONTROL CONTROL CONTROL FLUORESCENCE
rubeola (NIH) 
rubeola (Flow)
PI-3
NDV
mumps
RSV
Hunt virus
Hunt virus preserum
+ 1
+ 4
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Figure 6 Positive fluorescence on Hunt virus infected Vero cells 400 X
Figure 7 No fluorescence on Hunt virus infected Vero 
400 X
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COMPARISON OF PARAMYXOVIRUS CPE TO THAT OF THE ISOLATE
As stated earlier the electron microscopic preparation 
of the Hunt virus was identified morphologically as a para­
myxovirus, Since syncytia and inclusion bodies in tissue 
culture also were similar to those formed by the paramyxo­
viruses, developing stages of CPE by rubeola, parainflu­
enza 3 and RSV were compared to those formed by the Hunt 
virus,
Vero cell monolayers cultured in Leighton tubes were 
infected with the different viruses and one slide of each 
was washed, fixed and stained with hematoxylin and eosin.
In 2-day parainfluenza 3 and 3-day RSV infected cul­
tures (figures 9 & 10) eosinophilic cytoplasmic inclus­
ions were also seen in single cells in the parainfluenza 3 
infected cells but not in those infected with RSV. Rubeola 
infected cultured were still void of polykaryotic cells at 
this early period, but cells infected with the Hunt virus 
were already forming small syncytia with both nuclear and 
cytoplasmic eosinophilic inclusions. The inclusions were 
even formed in the nuclei of unfused cells.
As CPE progressed, differences became more pronounced. 
Beyond 3 days of incubation the size of parainfluenza 3 
syncytia developed rapidly, and the size of each syncytia 
had increased (figure 13) with cell degeneration following 
soon thereafter (figure 17). The RSV cytopathology devel­
oped slower as noted in the 6-day infected cultures (fig.14)
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The size of each syncytia had increased in size. In both 
the parainfluenza 3 and RSV cultures only cytoplasmic in­
clusions were again evident without formation of any intra­
nuclear inclusions (figures 17 & 18). At 6 days of infection 
by rubeola virus (figure 15) eosinophilic nuclear and cyto­
plasmic inclusions had developed. Throughout extensive 
multinucleation which contained as much as 50 nuclei per 
syncytium, shapes of the nuclear inclusions were circular 
to oblonged, fusing with other neighboring inclusions to 
form pleomorphic masses often encompassing the entire 
nucleus by the tenth day of infection (figure 19). As CPE 
developed in cells infected with the isolate nuclear in­
clusions were larger then the nucleoli without fusing to 
form pleomorphic bodies (figure 20).
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Figure 8 Hematoxylin and eosin stain of 6-day 
Hunt virus infected Vero cells
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¥a .
Figure 9 Two-day PI-3 infection in Vero cells 200 X
Figure 10 Three-day RSV infection in Vero cells 200 X
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Figure 11 Two-day infection with the Huntvirus on Vero cells 200 X
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Figure 12 Three-day PI-3 infection in Vero cells 200 X
Figure 13 Six-day RSV infection in Vero
cells 200 X
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Figure 14 Six-day infection of rubeola in Vero cells 400 X
Î
m
Figure 15 Four-day Hunt virus infection inVero cells 200 X
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Figure 16 Four-day PI—3 infection in Vero cells 200 X
m
Figure 17 Ten-day RSV infection in Vero
cells 200 X
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Figure 18 Ten-day rubeola infection in Vero 400 X
Figure 19 Eight-day infection with the Hunt
Virus in Vero cells 400 X
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Figure 20 Normal 2-day Vero cells 200 X
Figure 21 Normal 6-day Vero cells 200 X
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«
Figure 22 Normal 10-day Vero cells 200 X
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SUSCEPTIBILITY OF CULTURED CELLS
Some viruses are capable of infecting a wide variety 
of cultured cells derived from different organs as well as 
species. To determine the range of the infectiveness of the 
Hunt virus, comparative studies were conducted with rubeola 
virus using cultured cells from various sources. Cell mono­
layers were cultivated for one day before inoculating with
0.2 ml of virus suspension per tube. When CPE was observed 
the slides were removed, washed, fixed, then stained with 
hematoxylin and eosin. Those without noticable CPE were 
observed daily until the end of a two week period after 
which time the cells were fixed and stained.
As shown in table 16, the Hunt virus was able to infect 
all the cell lines tested based on syncytium or on appear­
ance of eosinophilic cytoplasmic and nuclear inclusion bodies 
Although the cells derived from tissues of bovine, rabbit, 
pig, mink origin or on human fibroblastic cells may have 
supported rubeola virus replication, morphological changes 
were not evident in these cells.
ANIMAL SUSCEPTIBILITY
Although not relevant in most cases in the scheme to 
identify a virus, determining the pathogenicity for labor­
atory animals could be valuable information. Since the iso­
late appears to be a new agent not previously described, the 
virulence factor could be important, particularly since the
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isolation was made from a rectal swab taken from an 
acutely ill infant. As a preliminary study, a limited 
experiment was conducted to determine the pathogenic po­
tential for certain animals. Rubeola virus was again in­
cluded for comparative purposes and as an added control.
Two newborn litters of Swiss Webster outbread mice from 
the Rocky Mountain Laboratory less than 24 hours old were 
pooled and randomly selected into 2 groups, each of which 
were inoculated with rubeola or the isolate. Of the 6 mice 
in each litter, 3 were injected intraperitoneally and 3 
intracerebrally with 0.03 ml of virus suspension. Add­
itional newborn animals were also injected with the same 
volumes of suspension medium only through the same routes.
Fertile chicken eggs were obtained through the Rocky 
Mountain Laboratory in Hamilton, Montana, and were incubat­
ed at 39 C in a mechanical egg incubator until hatched.
Nine chicks were included in the experiment with 3 receiv­
ing rubeola, 3 the isolate and 3 with the suspension med­
ium.
As shown in table 17, no animals developed visual 
signs of infection during the one month observation period.
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Table 16 Comparison of cell susceptibility to 
rubeola and the Hunt virus
CELL CULTURE & ORIGIN CYTOPATHIC CHANGES
HUNT VIRUS RUBEOLA
HEK-human kidney + +
Vero-monkey kidney + +
HeLa-human cervix + +
HF-human foreskin + —
HL-human lung + -
BSC-1 monkey kidney + +
Bovine salivary gland* + -
Bovine thymus* + -
Chick embryo fibroblasts* + +
Pig kidney + -
Mink lung + —
Guinea pig kidney* + —
Dog kidney + +
Rabbit kidney* + —
Rabbit cornea* + —
(-) no changes between "infected" and control cultures 
(+) cells undergoing syncytium and nuclear inclusions
(*) primary cultured cells
Table 17 Pathogenicity of the Hunt virus and rubeola for 
chicks and newborn mice
VIRUS ANIMALS PATHOGENICITY OBSERVEDAFTER ONE MONTH
rubeola
controls
chicks injected (ip) no
mice injected (ip) no
mice injected (ic) no
chicks injected (ip) no
mice injected (ip) no
mice injected (ic) no
chicks injected (ip) no
mice injected (ip) no
mice injected (ic) no
chicks not injecated no
mice not injected no
(ip) intraperitoneally (ic) intracerebrally
CHAPTER 4 
DISCUSSION
Since many bacteria, chlamydia, mycoplasma, protozoa, 
and viruses can cause infections of the respiratory tract, 
the etiological agent should be isolated to determine the 
specific causes of the respiratory distress. One would 
expect then that the specimens be taken from the naso­
pharyngeal secretions or throat swabs or gargles. With 
respiratory diseases caused by picornaviruses, rectal swabs 
are frequently another excellent source for isolation since 
they are able to pass through the low pH of the alimentary 
tract (82, 98). Rectal swabs are considered a poor select­
ion for paramyxoviruses since these agents do not repli­
cate in cells of the intestinal system and are unable to 
withstand low pH conditions (7 5, 98).
In an actual clinical laboratory situation, samples 
from multiple sites are frequently included even where 
symptoms appear to involve only a single target organ. In 
the case of the patient, Diane Hunt, the attending 
physician. Dr. C. E. Bell, took precautions and collected 
both throat and rectal swabs. The specimens were sub­
sequently inoculated on appropriate cultured cells, but 
after several days of incubation, only the cells inoc­
ulated with the rectal specimen began to show cytopathic 
changes. Repeat isolation attempts made much later from the 
specimens stored at -70 C again resulted in isolation of the
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same agent from the rectal sample but not from the trans­
port medium containing the throat swab. The Hunt virus, 
stable at pH 3.0, could have tolerated the alimentary tract 
conditions and could explain its isolation from the rectal 
specimen.
Initially the Hunt virus was tentatively thought to 
be rubeola based on cytopathic changes observed in inoc­
ulated cells as synctia with nuclear and cytoplasmic 
eosinophilic inclusions. According to the clinical pic­
ture however, no rash, high fever or cough were present. 
Also, the child had been vaccinated against rubeola two 
years earlier and a serum neutralization assay indicated 
that the titer of the convalescent serum sample against 
rubeola virus remained virtually unchanged at 256 indi­
cation rubeola virus was not associated with the pneumonia 
of Diane Hunt. Finally, the failure of specific rubeola 
antibodies to neutralize the Hunt virus indicated that the 
virus isolated required further characterization.
Electron microscopy studies determined that the Hunt 
virus resembled the paramyxoviruses. Briefly reviewing 
the paramyxoviruses, they all share many common proper­
ties (table 2). Morphologically these single stranded 
RNA viruses are highly pleomorphic ranging in size from 
100-300 nm and contain lipid envelopes required for their 
infectivity. Exposures to 56 C heat or pH 3.0 rapidly 
inactivate all members.
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Minor detectable difference between each member exists. 
Parainfluenza, NDV and mumps agglutinate guinea pig or chick 
red blood cells. Rubeola which does not agglutinate those 
cells, will with rheusus monkey cells, being the only para­
myxovirus with that distinction. In tissue culture all 
members produce syncytia. Parainfluenza, RSV, mumps and 
occasionally NDV produce eosinophilic cytoplasmic inclus­
ions. Rubeola is the only human virus which induces both 
eosinophilic cytoplasmic and nuclear inclusions.
Only three viruses produce CPE consisting of syncytia 
and eosinophilic nuclear and cytoplasmic inclusions, in­
cluding canine distemper, rinderpest and rubeola (56, 92).
The major differences between these viruses is in the host 
they infect, since their morphological and phsiochemical 
properties are identical (56). Even the signs and symptoms 
of the host are similar in the respiratory distress caused. 
Canine distemper is specific for dogs and rinderpest for 
cattle. No isolation of rinderpest in the United States 
have been reported (56), Rubeola infects only primates 
and humans.
The only other group of human viruses that produce 
syncytia is the herpesviruses (37, 38). These enveloped 
viruses contain double stranded DNA and are 110-220 nm in 
diameter. Stained infected cultures exhibit rounding in 
foci and eosinophilic nuclear inclusions.
In many aspects the isolate resembles paramyxoviruses. 
Filtration and electron microscopy studies determined the
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size of the Hunt virus to be 100-220 nm in diameter.
Failure of Actinomycin D to inhibit replication and stain­
ing of infected cells with acridine orange suggested that 
it was single stranded RNA. Sensitivity to ether and 
chloroform confirmed electron microscopy that the virus 
contained a lipid envelope. Similar to rubeola, the Hunt 
virus would not agglutinate several animal red blood cells 
including guinea pig and chick, but did with rhesus 
monkey cells. The cytopathology observed in tissue cul­
ture is almost identical to rubeola, producing syncytia 
with both eosinophilic cytoplasmic and nuclear inclusions.
Other properties were not consistent with the para­
myxoviruses. When the virus was exposed to heat at 56 C 
for 90 min or one hour at pH 3.0, conditions which rapidly 
inactivates paramyxoviruses, infectivity was retained.
Serological evidence suggests that the Hunt virus is 
distinctly different from rubeola or the other paramyxo­
viruses. Serum neutralization and fluorescent antibody 
assays demonstrated that specific antisera to the Hunt 
virus did not react with the paramyxoviruses and anti­
sera to the paramyxovirus and lacked antibodies to the 
Hunt virus. One rubeola antisera pool gave slight posi­
tive fluorescence against the Hunt virus, however, no 
antibodies in this pool could be detected by serum neu­
tralization. Another rubeola antisera pool obtained from 
Flow Laboratories in Bethesda, Maryland, did not give
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fluorescence, and an IFA performed by the California Depart­
ment of Health, Viral and Rickettsial Division, did not show 
any fluorescence with rubeola antisera. The slight "+1" 
positive may have been due to cross reactivity with a close­
ly related virus, or the animal in which the rubeola anti­
sera was prepared could have been exposed previously to 
the Hunt virus. Since serological evidence suggested animals 
other than humans may contain antibodies to the Hunt virus
the latter could be possible.
Three requirements necessary to demonstrate that an 
agent was involved in a recent infection of Diane Hunt had 
been satisfied : 1) cytopathic changes were produced in
tissue culture following the inoculation of the rectal 
specimen, 2) the agent was isolated and characterized 
and 3) a significant 16-fold titer increase from 32 to
512 to the isolate had been demonstrated.
Even though parainfluenza 3 was not isolated it also 
could have been involved in the infection. A significant 
4-fold titer increase in the acute to convalescent sera 
was detected by serum neutralization. Supporting sero­
logical evidence determined that parainfluenza 3 was not 
the same virus as the Hunt virus. Specific antisera would 
not cross react. Whether one or both agents were responsi­
ble for her respiratory condition is not known, but para­
influenza 3 is often involved in complicating pneumonia 
in children (11, 21, 22, 35, 40). However, parainfluenza 3
reinfections are common with the primary infection being the
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most severe and infecting children generally within the 
first year of life (40). Subsequent infections are much 
milder and often go unnoticed except for serological de­
tection of a rise in serological titer (41) .
Titers of the Hunt virus detected in other human and 
bovine sera suggested that the virus does not restrict its 
infectivity to man only. High titers to the virus in­
dicate that these antibodies are specific to the Hunt 
virus and not cross reactive to other viruses. Epidem­
iological and pathological studies in human and other an­
imals are essential to determine the role, if any, and 
incidence of infection to the respiratory system or other 
vital organs.
The Hunt virus appears to infect at least man and the 
bovine animals and perhaps other species as well, yet no 
reports of its isolation elsewhere have been found. The 
agent is possibly nonpathogenic, and the disease state of 
Diane Hunt was attributed to a third agent that was not 
isolated. Most diagnostic laboratories must rely on 
expediency for typing an unknown agent. Since the cult­
ural response of infected cells between the Hunt virus and 
rubeola virus are undistinguishable, the agent may have 
been isolated but not recognized. Even in serological 
analysis using rubeola virus test serum, the animal from 
which the measles antibody was made may also have been in­
fected earlier with the Hunt virus. Although the Missoula
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Diagnostic Laboratory uses cytopathic changes in cultures 
as only presumptive diagnosis, other laboratories may not 
complete the identification by serological evidence.
Based on the laboratory evidence, the Hunt virus 
appears to be a virus not previously identified. The agent 
possesses characteristics much like those of the para­
myxoviruses , but the classification may eventually be in a 
separate category by itself based on the distinct differ­
ences in the properties of heat and acid stabilities.
In conclusion, further studies are required for a better 
understanding of the Hunt virus. In addition to epide­
miology studies concerning humans and other animals, def­
initive identification of the nucleic acid and its config­
uration should be defined by extraction from the virions 
and chemically determined. Since the virus closely re­
sembles the paramyxoviruses, all of which possess trans­
criptase, it would be of interest to determine if replica­
tion requires a transcriptase and if so whether this might 
be a protein responsible for stability to acid and heat 
conditions. Stability may eventually prove to be a feature 
of a transcriptase, coat protein, lipid envelope or a 
combination of each.
CHAPTER 5 
SUMMARY
A virus was isolated from a rectal swab taken from 
a three year old girl diagnosed with pneumonia. Path­
ology of infected tissue culture cells consisted of syn­
cytia with eosinophilic nuclear and cytoplasmic inclusions 
closely resembling that of rubeola. Morphologically the 
isolate appeared to be a paramyxovirus, but specific anti­
sera to the human paramyxoviruses failed to neutralize the 
infectivity for cultured cells.
Further virus characterization displayed many prop­
erties similar to those of the paramyxoviruses. The 
virus was found to contain single stranded RNA packaged 
in enveloped virions measuring 100-220 nm in diameter. 
Hemagglutinin was capable of binding only rhesus monkey 
red blood cells.
Other properties not consistent with those of the 
paramysoviruses were stabilities to pH 3.0 and 56 C.
These conditions inactivate rapidly all of the known 
paramyxoviruses.
The involvement of the virus in the infection was 
suggested by a significant titer increase in convales­
cent serum of the patient to the isolate. An increase 
titer to parainfluenza 3 was also detected suggesting the 
patient had been dually infected.
Antibodies against the Hunt virus were present in
several bovine and human sera, some with titers as high
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as 1024. The results suggest that the virus is not species 
specific nor is it a new genetic creation originating from 
the patient.
According to the accepted scheme for virus classifi­
cation, the virus should be considered as a paramyxovirus. 
Since serology and physiochemical properties do not fit any 
paramyxovirus member, a new grouping of the Paramyxoviridae 
may be in order. Naming and classification is constantly 
changing. For this reason naming should be the responsi­
bility of the International Committee of Taxonomy of Viruses.
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